Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: Low Doses of Aspirin in the Prevention of Preeclampsia [Phase 3]

View source ↗

Summary

This document notes the completion of a Phase 3 trial evaluating low-dose aspirin for the prevention of preeclampsia and the posting of its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Preeclampsia | Phase 3 | Status: COMPLETED | Results posted: 2025-03-13